Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP248-ATP248, February 1, 2025. 0.003-0.42], p=0.008), and longer stenosis (1.24[1.03-1.50], 1.39], p<0.001), and diffuse involvement of MCA stenosis (4.55[1.40-14.74], Longer pre-stent balloon length was significantly associated with perforator SBIs (13.52.5

Angioplasty 40

Angioplasty Stent Stents Stenosis 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP16-AWP16, February 1, 2025. We defined high-risk post-EVT stenosis as any stenosis with 50% lumen stenosis, associated dissection, re-occlusion during thrombectomy, and severe residual luminal irregularity. female, mean age 63.9). p=0.030 respectively).Conclusions:Eptifibatide

Stenosis 40

Stenosis Thrombolysis Stroke Strokes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP252-AWP252, February 1, 2025. Baseline angiograms were reviewed to assess the presence or absence of intracranial stenosis lesions (IS+ Vs IS-) different than the target occlusion. Bailout strategies were required more often in the IS+ group (34.6% minutes; p=0.018). Vs 3; p=0.036).Conclusions:Our

Stenosis 40

Stenosis Outcomes Angioplasty Stent 40

Circulation

JANUARY 27, 2025

Circulation, Volume 151, Issue 12 , Page 835-846, March 25, 2025. BACKGROUND:In patients with post-thrombotic syndrome, stent recanalization of iliofemoral veins or the inferior vena cava can restore venous patency and improve functional outcomes.

Thrombosis 40

Thrombosis Stent Stents Quality of Life 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ADP39-ADP39, February 1, 2025. Background:Patients with atrial fibrillation were excluded from clinical trials evaluating carotid artery stent(CAS) or carotid endarterectomy (CEA).We We divided patients based on presence or absence of atrial fibrillation.

Atrial Fibrillation 40

Atrial Fibrillation Stent Stents Outcomes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page A71-A71, February 1, 2025. Background:The ideal timing of carotid artery stenting (CAS) in symptomatic internal carotid artery (ICA) stenosis is partly determined by the risk of stroke and/or death associated with timing of the procedure.

Stent 40

Stent Stents Stroke Strokes 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP178-ATP178, February 1, 2025. Background:Hyperperfusion phenomenon (HPP) constitutes a significant risk factor for adverse outcomes following carotid artery stenting (CAS). Currently, the sole method for evaluating the risk of HPP post-CAS is the invasive acetazolamide (ACZ) challenge test.

Stent 40

Stent Stents Stenosis Risk Factors 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP286-AWP286, February 1, 2025. Background:Hemodynamic evaluation is crucial in assessing stroke risk in patients with symptomatic intracranial atherosclerotic stenosis (sICAS). before PTAS. before PTAS.

Stenosis 40

Stenosis Stroke Strokes Angioplasty 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP128-ATP128, February 1, 2025. Background:Postoperative complication rates of carotid endarterectomy (CEA) and carotid artery stenting (CAS) for carotid artery stenosis are recommended to be maintained below a certain threshold.

Hospital 40

Hospital Stenosis Outcomes Inpatient 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATP229-ATP229, February 1, 2025. Background:Carotid artery stenting (CAS) and carotid endarterectomy (CEA) are two types of carotid revascularization procedures performed on symptomatic patients.

Stent 40

Stent Stents Lipid disorders Heart Failure 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATMP76-ATMP76, February 1, 2025. The time interval between the most recent qualifying ischemic event and CAS/CEA procedure was divided in four strata: 1-7 days, 8-14 days, 15-30 days and >30 days. versus 2.0%, p=0.68), at 15-30 days (5.1% versus 1.8%, p=0.26) days and >30 days (CAS 7.8%

Stent 40

Stent Stents Stroke Strokes 40

Circulation: Cardiovascular Interventions

JANUARY 20, 2025

Circulation: Cardiovascular Interventions, Volume 18, Issue 1 , Page e014665, January 1, 2025. BACKGROUND:Bioresorbable scaffolds (BRS) were developed to overcome limitations related to late stent failures of drug-eluting stents, but lumen reductions over time after implantation of BRS have been reported.

Stenosis 40

Stenosis Ultrasound Stent Stents 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page A41-A41, February 1, 2025. Introduction:Current guidelines do not support the use of stenting for severe symptomatic intracranial atherosclerotic disease (ICAD) over maximal medical therapy (MMT) as first line treatment. Periprocedural stroke was defined as <7d from stent placement.

Stroke 40

Stroke Strokes Stent Stents 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATMP58-ATMP58, February 1, 2025. ml/h, P = 0.04), a higher likelihood of parent artery stenosis (65% vs. 20.8%, P < 0.001), and increased need for angioplasty or stenting (50% vs. 17%, P < 0.001). ml/h vs. 7.5 The mismatch group also had a higher DWIR% (37.7%

Outcomes 40

Outcomes Stroke Strokes Angioplasty 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page ATMP10-ATMP10, February 1, 2025. Introduction:An optimal strategy for the treatment of intracranial atherosclerotic disease (ICAD) has remained unclear, despite medical therapy (antiplatelet therapy and LDL control management) or endovascular therapy (angioplasty or stenting).

Stenosis 40

Stenosis Plaque Angioplasty Stroke 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page A80-A80, February 1, 2025. In-stent stenosis occurred in 2.2% (17) and was associated with fusiform morphology at 1 year FU (OR, 4.82, 95% CI, 1.28 -14.35; p=0.018).Conclusion:Treatment Fusiform morphology was associated with in-stent stenosis. 2.56; p=0.076).

Aneurysm 40

Aneurysm Stent Stents Stenosis 40

Cardiometabolic Health Congress

JANUARY 2, 2025

August 2024 Approvals Minima Stent System (P240003) (Approval Date: August 28, 2024) The Minima Stent System is an expandable cobalt-chromium metal mesh tube to reopen blood vessels in neonates, infants, and children with Coarctation of the Aorta and Pulmonary Artery Stenosis, specifically designed to expand as younger patients grow.

Coronary Artery Disease 52

Coronary Artery Disease Stent Stents Innovation 52

Dr. S. Venkatesan MD

JANUARY 1, 2025

Welcome to 2025 and best wishes for a great academic journey to all readers. Top 10 Clinical Trials Preventive PCI on Stenosis With Functionally Insignificant Vulnerable Plaque PREVENT (ACC.24) Top 10 Clinical Trials Preventive PCI on Stenosis With Functionally Insignificant Vulnerable Plaque PREVENT (ACC.24)

Cardiogenic Shock 59

Cardiogenic Shock Plaque Academic Bicuspid/Mitral 59

Dr. Smith's ECG Blog

MARCH 9, 2025

The proximal and mid LAD stenoses were stented and the OM 2 was left alone. In this case, it is possible that the physicians interpreted the ST depression in anterior leads as subendocardial ischemia of the anterior wall, and the mid LAD stenosis as the culprit of that ischemia. 5 years later ( now in 2025 ) the problem remains.

Ischemia 88

Ischemia Blog STEMI Coronary Angiogram 88